An Intervention to Reduce Inappropriate Prescriptions for Elderly Patients in General Practice
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00281450|
Recruitment Status : Completed
First Posted : January 24, 2006
Last Update Posted : April 28, 2010
|Condition or disease||Intervention/treatment||Phase|
|Aged Family Practice||Behavioral: Educational intervention||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||85836 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice|
|Study Start Date :||January 2006|
|Actual Primary Completion Date :||March 2007|
|Actual Study Completion Date :||March 2007|
- Behavioral: Educational intervention
We developed a set of explicit criteria for pharmacological inappropriateness for Norwegian GPs' prescribing to elderly patients. The main purpose of the criteria was to serve as quality indicators during an educational intervention: the Prescription Peer Academic Detailing (Rx-PAD) Study, aimed at improving GPs' prescribing for elderly patients.
- Changes in a set of predefined quality indicators measuring appropriateness of prescriptions for elderly out-patients [ Time Frame: 1 year ]Prescription data for 1 year were retrospectively retrieved from the Norwegian Prescription Database (NorPD) and assessed in relation to 13 prescription quality indicators.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00281450
|Principal Investigator:||Sture Rognstad, MD||University of Oslo|